MDI and DPI Drug Products
...establish a set of criteria to which a drug substance or drug product should conform using.....manufacturing, processing, packaging, controls, stability testing, or labeling operations.....of each facility involved in the manufacturing of the drug substance and excipients should..
http://www.fda.gov/cder/guidance/2180dft.pdf (score=100)
stability guidance -draft
...this guidance to mean a batch of drug substance or drug product manufactured at the scale typically encountered.....compromise the quality, purity, or stability of the drug substance and the resulting drug.....satisfactory product stability, which may in turn include, but not be limited to, full long-term..
http://www.fda.gov/cder/guidance/1707dft.pdf (score=74)
Guidance for Industry: Nonsterile Semisolid Dosage Forms
...contains a drug substance, generally, but not necessarily, in association with one or more.....precision, linearity of standard curves, and adequate sensitivity, recovery, and stability.....batch should be compared with the release rate of the product prepared after a change as..
http://www.fda.gov/cder/guidance/1447fnl.pdf (score=73)
þÿ
...2 This guidance has been prepared by Drug Substance Technical Subcommittee of the Chemistry.....18 The applicant and/or drug product manufacturer must establish the reliability of the.....should explain the scientific reasons why a stability indicating procedure is not viable..
http://www.fda.gov/cder/guidance/3969DFT.pdf (score=70)
þÿ
...2 This guidance has been prepared by Drug Substance Technical Subcommittee of the Chemistry.....18 The applicant and/or drug product manufacturer must establish the reliability of the.....should explain the scientific reasons why a stability indicating procedure is not viable..
http://www.fda.gov/OHRMS/DOCKETS/98fr/2003d-0571-gdl0001.pdf (score=69)
...1 Influence on Manufacturing of the Drug Product Drug substance polymorphic forms can also exhibit different.....The extent of conversion generally depends on the relative stability of the polymorphs.....For example, in one approved drug product, the drug substance can exist in at least twenty polymorphic forms, but..
http://www.fda.gov/cder/guidance/6154dft.doc (score=61)
Guidance- Content & Format CMC for Vaccine & Related Product
...A list should be provided of all components in the drug product, including drug substance(s)and other ingredients, with.....This section should contain information on the stability of the drug substance and any in.....the evidence derived from validation studies which assures that product identity, purity, potency, and stability is preserved for..
http://www.fda.gov/cber/gdlns/cmcvacc.pdf (score=60)
Validation of Chromatographic Methods
...Solution stability of the drug substance or drug product after preparation..according to the test method should be evaluated.....with the regulatory impurities method relating to release and stability of..both drug substance and drug product.Detection limit is.....HPL Chromatographic Methods for Drug Substance and Drug Product. Methods should not be validated as a one-time..
http://www.fda.gov/cder/guidance/cmc3.pdf (score=52)
Microsoft Word - 5320.1.doc
...6 ONLY if the drug substance is sterile or if..other product quality microbiology issues are.....2 Post-Approval Stability Protocol and Stability Commitment.. Analytical procedures and testing schedule for.....Description of the Composition of the Drug Product..Description of the drug product composition..
http://www.fda.gov/cder/mapp/5320.1.pdf (score=49)
Substance
...individual batches of the drug substance used in animal and clinical testing, Drug Substance.....relation to the amount of crude product, whether it is filtered while hot, whether a.....Stability.. The regulations require a full description of the stability of the drug..
http://www.fda.gov/cder/guidance/drugsub.pdf (score=49)
Q1B Photostability Testing of New Drug Substances and Products
...This testing may involve the drug substance alone and/or in simple solutions/suspensions to.....The extent of drug product testing should be established by assessing whether or not acceptable.....The ICH Harmonized Tripartite Guideline on Stability Testing of New Drug Substances and..
http://www.fda.gov/cder/guidance/1318.htm (score=48)
Microsoft Word - 5020.1.doc
...6 ONLY if the drug substance is sterile or if..other product quality microbiology issues are.....2 Post-Approval Stability Protocol and Stability Commitment.. Analytical procedures and testing schedule for.....Description of the Composition of the Drug Product..Description of the drug product composition..
http://www.fda.gov/cder/mapp/5020.1.pdf (score=48)
Content and Format of INDs for Phase 1 Studies of Drugs, Inclu
...of the IND to demonstrate that the new drug substance and drug product..are within acceptable chemical and.....used to monitor the stability of the drug product packaged in..the proposed container.....Information to support the stability of the drug..substance during the toxicologic studies..
http://www.fda.gov/cder/guidance/clin2.pdf (score=47)
IND content and format for Phase 1 studies
...As clinical development of a drug product proceeds,sponsors should discuss the manufacturing.....Information to support the stability of the drug..substance during the toxicologic studies.....manufacture of the investigational drug product,including both those components intended to..
http://www.fda.gov/cder/guidance/phase1.pdf (score=47)
Format and Content for the CMC Section of an Annual Report
...Regulatory specifications and analytical methods for the drug substance and drug..product should be listed.....the design of stability protocols, the amount of stability data that should be provided to.....Methods for the drug substance and drug product in the format provided. III. SPECIFICATIONS AND METHODS FOR THE..
http://www.fda.gov/cder/guidance/cmc1.pdf (score=47)
GUIDE TO INSPECTIONS OF TOPICAL DRUG PRODUCTS
...If the drug substance is soluble, then potency uniformity would be based largely upon adequate.....Excessive temperatures may cause physical and/or chemical degradation of the drug product.....In addition, preservative effectiveness must be monitored as part of the final on-going..
http://www.fda.gov/ora/inspect_ref/igs/topic.html (score=44)
ichq5c
...either drug substance or drug product should be based on long-term, real-time, real.....entity and the quantitative detection of degradation products should also be part of the.....protein, peptide, inorganic mineral)with the objective of improving the efficacy or stability of the..
http://www.fda.gov/cder/guidance/ichq5c.pdf (score=44)
GUIDE TO INSPECTIONS OF BULK PHARMACEUTICAL CHEMICALS
...Related substances are defined as those structurally related to a drug substance such as a degradation product or impurities.....This, together with the generally widespread existence of stability testing programs, make.....The USP also notes that the impurity profile of a drug substance is a description of the..
http://www.fda.gov/ora/inspect_ref/igs/bulk.html (score=43)
6003dft.doc
...contractual arrangement to produce the intermediates, drug substance, or drug product on behalf.....therefore, real-time concurrent stability studies on the product potentially affected by.....changes and that no adverse impact on the quality, safety, or efficacy of the drug product..
http://www.fda.gov/cder/guidance/6003dft.pdf (score=68)
Draft Guidance: ICH Q5E: Comparability of Biotechnological/Biological...
...The tests and analytical procedures chosen to define drug substance or drug product specifications alone are.....Generally, therefore, real-time concurrent stability studies on the product potentially.....Therefore, it might be appropriate to collect data on the drug product to support the..
http://www.fda.gov/cber/gdlns/ichcompbio.htm (score=67)
Powered by viXML, providing custom search results
Las Vegas Injury Lawyer
